NPPA'S HELPLINE NO. 1800111255
Screen Reader Access
Skip to main content
A
-
A
A
+
हिंदी
Control Room Helpline No.-1800111255
Email at -
monitoring-nppa(at)gov(dot)in
Dashboard
Frequently Asked Questions(FAQ)
Toggle navigation
About Us
About NPPA
Message of Chairman
Resolution – Government of India
Act and Rules
Functions & Responsibilities
Organization Chart
Who’s Who
Print Media Gallery
Drug Policy
Drug Policy 1986
Amendment to the Drug Policy 1986
Pharmaceutical Policy 2002
National Pharmaceutical Pricing Policy, 2012
DPCO
Drug (Price Control) Order 1995
DRUGS (PRICES CONTROL) ORDER, 2013
Delegation of Powers under DPCO 2013
STUDY ON DRUG PRICES
Resources
Authority Minutes
Experts Committee
Year 2022-2023
Year 2021-2022
Year 2020-2021
Year 2019-2020
Year 2018-2019
Year 2017-2018
Year 2016-2017
Year 2015-2016
Year 2014-2015
Year 2013-2014
Reports
Utilities
Compendium of Prices
National List of Essential Medicines
NLEM 2011
NLEM 2015
List of Bulk Drugs Under DPCO 1995
Overcharging Status
Year 2022
Year 2021
Year 2020
Year 2019
Year 2018
Year 2017
Year 2016
Year 2015
Year 2014
Year 2013
Exemption Orders
State Drug Controller
List of Notified Prices
DPCO 2013
DPCO 1995
NLEM Stakeholder Consultation
Internal Guidelines
Related Websites
Therapeutic Category Wise Ceiling Price List
Online Services
Medical Devices
IPDMS 2.0
Pharma Jan Samadhan
IPDMS Registration
Pharma Sahi Daam / Search Medicine Price
What’s New
Tender Notices
Circulars/Orders
News/Press Coverage
Ecosystem
Status of Price Application
List of Approved Form IV
Recruitment
Archive
Schemes
CAPPMS
PMRU
CAPPMS Guidelines
Discontinuation
Guidelines for Discontinuation of Scheduled Formulation
Format for Form IV
Format for Public Notice
Submission of Form IV
List of Approved Form IV
Right to Information
Right to Information Act
Central Public Information Officer
Proactive Disclosure
RTI Online Application/ Appeal
Media
Photo Gallery
Video Gallery
Publication
Newsletter
Book
Contact us
Home
>
Whats New
>
Inviting comments on – Draft guidelines for dealing cases of discontinuation of scheduled formulations under Para 21 (2) of DPCO,2013.
Inviting comments on – Draft guidelines for dealing cases of discontinuation of scheduled formulations under Para 21 (2) of DPCO,2013.
Inviting comments on – Draft guidelines for dealing cases of discontinuation of scheduled formulations under Para 21 (2) of DPCO,2013.
Last Page Updated: 02-06-2020
Previous
Next
Previous
Next
×
